Methodist the only practical testing ground for the development of the technology will be.

BSL-3 pathogens, the tuberculosis tuberculosis. ‘This imaging system will be the first of its kind,’said James M. Of the Department of Pathology and Laboratory Medicine and Director, Center for Molecular and Translational Human Infectious Diseases Research at the Methodist Hospital. ‘Our system will translate translate important new insights into the clinic and enables rapid development of new diagnostic strategies and evaluation of new therapeutics and vaccines. ‘.. Methodist the only practical testing ground for the development of the technology will be.The purpose the suite is the pathogens, the security level of study 3 require containment.

One of the project objectives is the primary goal, Li said, is a similar device fitted to infectious diseases in a large influx of patients develop is diagnosed. ‘When the partnership with Philips is successful, the Methodist Hospital Research Institute, to develop the next steps for the creation the the only hospital in the world explicitly image patients with infectious agents, such as multi – drug-resistant TB,’Li said. ‘This medical centers medical centers in the world and be better prepared for emerging diseases and bioterrorism.’.Alberto Gutierrez, director by the Office for In Vitro Diagnostic Device Evaluation and Safety at the FDA Center for Devices and Radiological Health, said: – bloodstream infections to be treated having antimicrobial active ingredients increasingly, and is important to recognize gram-negative any is appropriate for a certain patients as soon as possible. An important means an important tool that can help doctors treat patient soon with the right antibiotics. ‘.

The test is is known as a Verigene Grand Prix Blood Culture Holder Nucleic Acid Test able to provide various types of Staphylococcus, identify , Streptococcus Enterococcus and Listeria.

Random entries

Other entries from category "venereology":